Abstract:The proinflammatory cytokine tumor necrosis factor-alpha (TNFα) exists naturally in two forms, a 26 kDa transmembrane form (TM-TNFα), and a 17 kDa secretory form (S-TNFα). The biological roles for each of these forms of TNFα in tumor killing have not been completely elucidated. Therefore, in this study, three different recombinant retroviral vectors, wild-type TNFα, solely secretable TNFα mutant, and uncleavable transmembrane TNFα mutant, were constructed by molecular techniques and stably transfected into a murine hepatic carcinoma cell line (H22). TNFα, either secreted in cell culture supernatants by secretable TNFα mutant- or wild-type TNFα-producing tumor cells, or as a treansmembrane form expressed on the cell surface of uncleavable TNFα mutant- or wild-type TNFα-synthesizing tumor cells, was demonstrated to be cytotoxic against the TNF sensitive L929 cell line. The H22 cells transfected with the three different forms of TNFα were shown to kill parental H22 cells in an in vitro cytotoxicity assay [effect/target (E/T) ratio-dependent manner], and their maximal killing rates were ~38–43% at E/T ratio of 5:1. The injection of total 2.5×105 mixed cells containing transfected and parental H22 tumor cells at different ratios into syngeneic mice resulted in the inhibition of tumor growth with a maximal inhibition rates of ~57~72% at E/T ratio of 5:1. A transient weight loss was found in mice bearing solely secretable TNFα mutant producing tumors, whereas no obvious side effects were seen in mice bearing uncleavable TNFα mutant or wild-type TNFα expressing tumors. Finally, we demonstrate that tumors secreting S-TNFα promoted the subsequent infiltration of CD4+ T cells, and to a lesser extent CD8+ T cells, to the tumor site. The TM-TNFα expressing tumors up-regulated Fas (CD95) expression and inhibited the expression of tumor metastasis associated molecule CD44v3. These results suggest that S-TNFα and TM-TNFα kill cancer cells in vivo through different mechanisms of action. We conclude that the non-secreted form of TNFα may be an ideal candidate for cancer gene therapy due to its therapeutic potential and lowered side effect profile.

Tumor Necrosis Factor-Alpha Promotes Tumor Growth by Inducing Vascular Endothelial Growth Factor

Tumor Necrosis Factor- α Promotes the Tumorigenesis, Lymphangiogenesis, and Lymphatic Metastasis in Cervical Cancer via Activating VEGFC-Mediated AKT and ERK Pathways

HIF-1α acts downstream of TNF-α to inhibit vasodilator-stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells.

TNF‑α Inhibits Xenograft Tumor Formation by A549 Lung Cancer Cells in Nude Mice Via the HIF‑1α/VASP Signaling Pathway.

Clinical Significance and Advances Oftnfsf15 Modulation on Tumor Angiogenesis and Lymphangiogenesis

Tumor Necrosis Factor-Α Regulates Expression of Vascular Endothelial Growth Factor Via JNK and AP-1 Pathway in MCF-7 Cells

Jnk/Ap-1 Pathway is Involved in Tumor Necrosis Factor-Alpha Induced Expression of Vascular Endothelial Growth Factor in Mcf7 Cells

Tumor Necrosis Factor-Α Promotes Hepatocellular Carcinogenesis Through the Activation of Hepatic Progenitor Cells.

Hypoxia-induced Factor-1 Alpha Upregulates Vascular Endothelial Growth Factor C to Promote Lymphangiogenesis and Angiogenesis in Breast Cancer Patients

TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells

Data from Angiopoietin-1 Overexpression Modulates Vascular Endothelium to Facilitate Tumor Cell Dissemination and Metastasis Establishment

TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling

Tumor-Derived Microrna-494 Promotes Angiogenesis in Non-Small Cell Lung Cancer

Tumor Necrosis Factor Α Induces Myofibroblast Differentiation in Human Tongue Cancer and Promotes Invasiveness and Angiogenesis Via Secretion of Stromal Cell-Derived Factor-1

Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1

Early Growth Response Gene-1 and Hypoxia-Inducible Factor-1Α Affect Tumor Metastasis Via Regulation of Tissue Factor

HIF1α Counteracts TGFβ1-Driven TSP1 Expression in Endothelial Cells to Stimulate Angiogenesis in the Hypoxic Tumor Microenvironment

Mechanism of Action Differences in the Antitumor Effects of Transmembrane and Secretory Tumor Necrosis Factor-Alpha in Vitro and in Vivo.

A Low Level of Tumor Necrosis Factor Α in Tumor Microenvironment Maintains the Self-Renewal of Glioma Stem Cells by Vasorin-mediated Glycolysis

Tumor necrosis factor-α attenuates starvation-induced apoptosis through upregulation of ferritin heavy chain in hepatocellular carcinoma cells

Interleukin-17 Augments Tumor Necrosis Factor Α-Mediated Increase of Hypoxia-Inducible Factor-1Α and Inhibits Vasodilator-Stimulated Phosphoprotein Expression to Reduce the Adhesion of Breast Cancer Cells.